• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基因名称]多态性与早期乳腺癌的关联。 (你提供的原文中“and”前后缺少具体内容,请补充完整以便准确翻译)

Associations of and Polymorphisms with Early-Stage Breast Cancer.

作者信息

Bartnykaitė Agnė, Savukaitytė Aistė, Ugenskienė Rasa, Daukšaitė Monika, Korobeinikova Erika, Gudaitienė Jurgita, Juozaitytė Elona

机构信息

Oncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.

Department of Genetics and Molecular Medicine, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, LT-50161 Kaunas, Lithuania.

出版信息

J Clin Med. 2021 Feb 19;10(4):866. doi: 10.3390/jcm10040866.

DOI:10.3390/jcm10040866
PMID:33669778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7922970/
Abstract

Breast cancer is one of the most common cancers worldwide. Single nucleotide polymorphisms (SNPs) in and have been associated with various cancers. However, the influence on clinical characteristics of breast cancer has not been sufficiently investigated yet. Thus, this study aimed to investigate the relationship between SNPs in (rs2279744, rs937283, rs937282) and (rs1380576, rs4245739) and I-II stage breast cancer. For analysis, the genomic DNA was extracted from 100 unrelated women peripheral blood. Polymorphisms were analyzed with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. The study showed that rs937283 and rs937282 were significantly associated with estrogen receptor status and human epidermal growth factor receptor 2 (HER2) status. SNPs rs1380576 and rs4245739, located in , were significantly associated with status of estrogen and progesterone receptors. Our findings suggest that rs937283 AG, rs937282 CG, rs1380576 CC, and rs4245739 AA genotypes were linked to hormonal receptor positive breast cancer and may be useful genetic markers for disease assessment.

摘要

乳腺癌是全球最常见的癌症之一。[基因名称1]和[基因名称2]中的单核苷酸多态性(SNP)与多种癌症相关。然而,其对乳腺癌临床特征的影响尚未得到充分研究。因此,本研究旨在探讨[基因名称1](rs2279744、rs937283、rs937282)和[基因名称2](rs1380576、rs4245739)中的SNP与I-II期乳腺癌之间的关系。为进行分析,从100名无亲缘关系女性的外周血中提取基因组DNA。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析方法检测多态性。研究表明,rs937283和rs937282与雌激素受体状态和人表皮生长因子受体2(HER2)状态显著相关。位于[基因名称2]中的SNP rs1380576和rs4245739与雌激素和孕激素受体状态显著相关。我们的研究结果表明,rs937283 AG、rs937282 CG、rs1380576 CC和rs4245739 AA基因型与激素受体阳性乳腺癌相关,可能是用于疾病评估的有用遗传标记。

相似文献

1
Associations of and Polymorphisms with Early-Stage Breast Cancer.[基因名称]多态性与早期乳腺癌的关联。 (你提供的原文中“and”前后缺少具体内容,请补充完整以便准确翻译)
J Clin Med. 2021 Feb 19;10(4):866. doi: 10.3390/jcm10040866.
2
Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.MDM4 基因单核苷酸多态性与伊朗东南部人群乳腺癌易感性的关联。
Clin Breast Cancer. 2018 Oct;18(5):e883-e891. doi: 10.1016/j.clbc.2018.01.003. Epub 2018 Jan 31.
3
Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study.TP53基因rs1042522、MDM2基因rs2279744、rs3730485、MDM4基因rs4245739变异与急性髓系白血病易感性、风险分层评分及临床特征的关联分析:一项探索性研究
J Clin Med. 2020 Jun 1;9(6):1672. doi: 10.3390/jcm9061672.
4
Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility.MDM4基因rs4245739单核苷酸多态性与乳腺癌易感性的相关性分析。
Clin Lab. 2016 Jul 1;62(7):1303-1308. doi: 10.7754/Clin.Lab.2016.151128.
5
The associations between MDM4 gene polymorphisms and cancer risk.MDM4基因多态性与癌症风险之间的关联。
Oncotarget. 2016 Aug 23;7(34):55611-55623. doi: 10.18632/oncotarget.10877.
6
Sex-Specific Associations of and Variants with Risk of Multiple Primary Melanomas and Melanoma Survival in Non-Hispanic Whites.非西班牙裔白人中,基因变异与多原发性黑色素瘤风险及黑色素瘤生存率的性别特异性关联。
Cancers (Basel). 2023 May 11;15(10):2707. doi: 10.3390/cancers15102707.
7
MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.MDM4基因单核苷酸多态性34091(rs4245739)及其对乳腺癌、结肠癌、肺癌和前列腺癌风险的影响。
Cancer Med. 2015 Dec;4(12):1901-7. doi: 10.1002/cam4.555. Epub 2015 Oct 16.
8
Lack of Associations of the MDM4 rs4245739 Polymorphism with Risk of Thyroid Cancer among Iranian-Azeri Patients: a Case-Control Study.伊朗阿塞拜疆族患者中MDM4基因rs4245739多态性与甲状腺癌风险的关联性研究:一项病例对照研究
Asian Pac J Cancer Prev. 2017 Apr 1;18(4):1133-1138. doi: 10.22034/APJCP.2017.18.4.1133.
9
[Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].[小鼠双微体2与P53基因多态性与乳腺癌易感性的关联]
Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Feb;47(2):124-8.
10
Five gene polymorphisms on cancer risk: An updated systematic review and meta-analysis.五种与癌症风险相关的基因多态性:一项更新的系统评价和荟萃分析。
Int J Biol Markers. 2021 Jun;36(2):17246008211033874. doi: 10.1177/17246008211033874.

引用本文的文献

1
Genetic Variations in Gene Contribute to Renal Cell Carcinoma Susceptibility: A Genotype-Phenotype Correlation Study.基因中的遗传变异与肾细胞癌易感性相关:一项基因型-表型相关性研究。
Cancers (Basel). 2025 Jan 8;17(2):177. doi: 10.3390/cancers17020177.
2
TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds.乳腺癌和卵巢癌中的TP53突变与MDM2多态性:药物和天然化合物的改善作用
Clin Transl Oncol. 2025 Jan 11. doi: 10.1007/s12094-024-03841-6.
3
Personalized treatment approach for HER2-positive metastatic breast cancer.针对人表皮生长因子受体 2(HER2)阳性转移性乳腺癌的个体化治疗方法。
Med Oncol. 2024 Sep 25;41(11):252. doi: 10.1007/s12032-024-02504-4.
4
Multi-tissue transcriptome-wide association studies identified 235 genes for intrinsic subtypes of breast cancer.多组织转录组全基因组关联研究鉴定了 235 个乳腺癌内在亚型的基因。
J Natl Cancer Inst. 2024 Jul 1;116(7):1105-1115. doi: 10.1093/jnci/djae041.
5
The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis.龙血竭抑制 MCF-7 乳腺癌细胞增殖的作用及机制:基于网络药理学的分析。
Sci Rep. 2023 Mar 7;13(1):3816. doi: 10.1038/s41598-023-30585-0.
6
Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients.PI3K-AKT信号通路基因、KLF-14、MDM4、微小RNA 27a、微小RNA-196a基因改变对乳腺癌患者易感性及病情进展的潜在影响
Cancers (Basel). 2023 Feb 17;15(4):1281. doi: 10.3390/cancers15041281.
7
Current and Developing Liquid Biopsy Techniques for Breast Cancer.乳腺癌的当前及发展中的液体活检技术
Cancers (Basel). 2022 Apr 19;14(9):2052. doi: 10.3390/cancers14092052.
8
The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer.循环肿瘤DNA在乳腺癌管理中的新兴作用
Cancers (Basel). 2021 Jul 29;13(15):3813. doi: 10.3390/cancers13153813.

本文引用的文献

1
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.MDM2 抑制联合内分泌治疗和 CDK4/6 抑制治疗 ER 阳性乳腺癌。
Breast Cancer Res. 2020 Aug 12;22(1):87. doi: 10.1186/s13058-020-01318-2.
2
The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy.靶向 p53-MDM2/MDMX 的潜在小分子药物治疗癌症的过去、现在和未来。
Eur J Med Chem. 2019 Aug 15;176:92-104. doi: 10.1016/j.ejmech.2019.05.018. Epub 2019 May 8.
3
Specific allelic variants of SNPs in the and genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients.某些单核苷酸多态性(SNPs)在[具体基因名称1]和[具体基因名称2]基因中的特定等位基因变体与高加索乳腺癌患者更早的肿瘤发病和进展相关。 (注:原文中两个基因名称未给出具体信息,翻译时用[具体基因名称1]和[具体基因名称2]表示)
Oncotarget. 2019 Mar 8;10(20):1975-1992. doi: 10.18632/oncotarget.26768.
4
Association of the SNP285 and SNP309 Genetic Variants with the Risk, Age at Onset and Prognosis of Breast Cancer in Central European Women: A Hospital-Based Case-Control Study.中欧女性中 SNP285 和 SNP309 遗传变异与乳腺癌风险、发病年龄和预后的关联:一项基于医院的病例对照研究。
Int J Mol Sci. 2019 Jan 25;20(3):509. doi: 10.3390/ijms20030509.
5
The long and the short of it: the MDM4 tail so far.长话短说:迄今为止的 MDM4 尾巴。
J Mol Cell Biol. 2019 Mar 1;11(3):231-244. doi: 10.1093/jmcb/mjz007.
6
Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.MDMX(MDM4)和 MDM2 在乳腺癌增殖和循环肿瘤细胞中的上下文相关作用。
Breast Cancer Res. 2019 Jan 14;21(1):5. doi: 10.1186/s13058-018-1094-8.
7
Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment.MDM2 抑制剂使 p53 基因重新激活:癌症治疗的新疗法。
Biomed Pharmacother. 2019 Jan;109:484-492. doi: 10.1016/j.biopha.2018.10.155. Epub 2018 Nov 6.
8
The Study of MDM2 rs937283 Variant and Cancer Susceptibility in a Central Chinese Population.中国中部人群中MDM2 rs937283变异与癌症易感性的研究。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818801550. doi: 10.1177/1533033818801550.
9
Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population.土耳其人群中MDM2基因T309G多态性与乳腺癌风险的显著关联。
Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1059-1062. doi: 10.22034/APJCP.2018.19.4.1059.
10
Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.MDM4 基因单核苷酸多态性与伊朗东南部人群乳腺癌易感性的关联。
Clin Breast Cancer. 2018 Oct;18(5):e883-e891. doi: 10.1016/j.clbc.2018.01.003. Epub 2018 Jan 31.